Diseases, Conditions, Syndromes

Experimental immunotherapy zaps two most lethal Ebola virus strains

Researchers at Albert Einstein College of Medicine and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have engineered the first antibodies that can potently neutralize the two deadliest strains ...

Diseases, Conditions, Syndromes

Coronavirus in America: Keep your panic in check

(HealthDay)—A deadly virus that's surging through a foreign country makes its way into the United States, carried into this country by an unwitting traveler.

Medical research

Single vaccines to protect against both rabies and Ebola

Researchers from Thomas Jefferson University, among other institutions, including the National Institute of Allergy and Infectious Diseases, have developed single vaccines to protest against both rabies and the Ebola virus.

Diseases, Conditions, Syndromes

Researchers learn how Ebola virus disables the body's immune defenses

A new study by researchers from The University of Texas Medical Branch at Galveston uncovered new information on why the Ebola virus can exert such catastrophic effects on the infected person. They've described for the first ...

Diseases, Conditions, Syndromes

New SLeone Ebola case responding to treatment

A second new case of Ebola in Sierra Leone since west Africa celebrated the apparent end of the epidemic last week is responding well to treatment, an official said Friday.

Immunology

Researchers uncover how Ebola virus disables immune response

One of the human body's first responses to a viral infection is to make and release signaling proteins called interferons, which amplify the immune system response to viruses. Over time, many viruses have evolved to undermine ...

Diseases, Conditions, Syndromes

NIH begins testing Ebola treatment in early-stage trial

A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. The Phase 1 clinical trial is examining the safety ...

page 5 from 40